Thus, in stroke models, the use of GluN2B inhibitors such as ifenprodil, its derivatives, and Tat-NR2B9c peptide can effectively reduce the area of brain infarction (Gotti et al., 1988; Cook et al., 2012). Here, GRIN2B is linked to Stroke.